---
title: "Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=402600"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2019-11-21
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

The Food and Drug Administration approved tafenoquine for prophylaxis of malaria and antirelapse therapy.

## 詳細內容

The Food and Drug Administration approved tafenoquine for prophylaxis of malaria and antirelapse therapy.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:16:28Z*
*資料來源: CDC MMWR*
